Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) in the first study of a cardiac myosin inhibitor (CMI) in adolescents ...
Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...
Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback